ReviewInternational journal of molecular sciences2023
New Approaches in Early-Stage NSCL Management: Potential Use of PARP Inhibitors and Immunotherapy Combination.
Marta Pina Fernandes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.